Free Republic 3rd Qtr 2021 Fundraising Target: $88,000 Receipts & Pledges to-date: $29,701
33%  
Woo hoo!! And the first 33% is in!! Thank you all very much!! God bless.

Keyword: donanemab

Brevity: Headers | « Text »
  • Experimental Alzheimer's drug could slow cognitive decline in patients, early results suggest

    03/26/2021 8:03:09 AM PDT · by bitt · 15 replies
    CNN.COM ^ | 3/13/2021 | Lauren Mascarenhas
    Eli Lilly and Company's experimental intravenous drug donanemab could slow the cognitive decline of patients with Alzheimer's disease, according to early clinical trial results, published in The New England Journal of Medicine on Saturday. The study included 257 patients with early symptomatic Alzheimer's disease; 131 received donanemab, while 126 received a placebo. The researchers found donanemab slowed the decline of cognition and daily function in Alzheimer's patients by 32% after 76 weeks, compared to those who received a placebo. Taken over 18 months, that 32% slowing of decline could be noticeably impactful for Alzheimer's patients, noted Maria Carrillo, chief science...